Bellicum Pharmaceuticals


Dynavax Technologies Corporation (Nasdaq: DVAX) is a clinical-stage biopharmaceutical company with multiple product candidates in development for the prevention of infectious disease, the treatment of autoimmune and inflammatory diseases, and the treatment of cancer. They develop immunotherapies based on cutting-edge Toll-Like Receptor biology and its ability to modulate the immune system.